Title | Author(s) | Issue date | ???itemlist.??? |
The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasms | Hatzimichael, E.; Dasoula, A.; Benetatos, L.; Makis, A.; Stebbing, J.; Crook, T.; Syrrou, M.; Bourantas, K. L. | 24-Nov-2015 | - |
Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia | Hatzimichael, E.; Benetatos, L.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Georgiou, I.; Syrrou, M.; Stebbing, J.; Coley, H. M.; Crook, T.; Bourantas, K. L. | 24-Nov-2015 | - |
Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implications | Hatzimichael, E.; Dasoula, A.; Kounnis, V.; Benetatos, L.; Nigro, C. L.; Lattanzio, L.; Papoudou-Bai, A.; Dranitsaris, G.; Briasoulis, E.; Crook, T. | 24-Nov-2015 | - |
CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes | Benetatos, L.; Hatzimichael, E.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Syrrou, M.; Georgiou, I.; Bourantas, K. L. | 24-Nov-2015 | - |
Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient | Benetatos, L.; Hatzimichael, E.; Vassou, A.; Bourantas, K. L. | 24-Nov-2015 | - |
Cytokine and adhesion molecule expression evolves between the neutrophilic and lymphocytic phases of viral meningitis | Makis, A.; Shipway, D.; Hatzimichael, E.; Galanakis, E.; Pshezhetskiy, D.; Chaliasos, N.; Stebbing, J.; Siamopoulou, A. | 24-Nov-2015 | - |
Jun B Expression Is Associated with Non-GC (Germinal Center) B Cell Differentiation Immunophenotype, and Jun B and Jun D with High Proliferation of Tumor Cells in DLBCL. | Papoudou-Bai, A.; Batistatou, A.; Hatzimichael, E.; Dasoula, A.; Kanavaros, P.; Malamou-Mitsi, V. | 24-Nov-2015 | - |
Methylation analysis of the von Hippel-Lindau gene in acute myeloid leukaemia and myelodysplastic syndromes | Benetatos, L.; Dasoula, A.; Syed, N.; Hatzimichael, E.; Crook, T.; Bourantas, K. L. | 24-Nov-2015 | - |
NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity | Wang, H.; Lee, S.; Nigro, C. L.; Lattanzio, L.; Merlano, M.; Monteverde, M.; Matin, R.; Purdie, K.; Mladkova, N.; Bergamaschi, D.; Harwood, C.; Syed, N.; Szlosarek, P.; Briasoulis, E.; McHugh, A.; Thompson, A.; Evans, A.; Leigh, I.; Fleming, C.; Inman, G. J.; Hatzimichael, E.; Proby, C.; Crook, T. | 24-Nov-2015 | - |
Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions | Benetatos, L.; Dasoula, A.; Hatzimichael, E.; Syed, N.; Voukelatou, M.; Dranitsaris, G.; Bourantas, K. L.; Crook, T. | 24-Nov-2015 | - |
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia | Hatzimichael, E.; Dasoula, A.; Shah, R.; Syed, N.; Papoudou-Bai, A.; Coley, H. M.; Dranitsaris, G.; Bourantas, K. L.; Stebbing, J.; Crook, T. | 24-Nov-2015 | - |
Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma | Benetatos, L.; Dasoula, A.; Hatzimichael, E.; Georgiou, I.; Syrrou, M.; Bourantas, K. L. | 24-Nov-2015 | - |
Revisiting bleomycin from pathophysiology to safe clinical use | Froudarakis, M.; Hatzimichael, E.; Kyriazopoulou, L.; Lagos, K.; Pappas, P.; Tzakos, A. G.; Karavasilis, V.; Daliani, D.; Papandreou, C.; Briasoulis, E. | 24-Nov-2015 | - |
Serum adipocytokine and vascular inflammation marker levels in Beta-thalassaemia major patients | Chaliasos, N.; Challa, A.; Hatzimichael, E.; Koutsouka, F.; Bourantas, D.; Vlahos, A. P.; Siamopoulou, A.; Bourantas, K. L.; Makis, A. | 24-Nov-2015 | - |
Spontaneous splenic haematoma in a multiple myeloma patient receiving pegfilgrastim support | Hatzimichael, E.; Benetatos, L.; Stebbing, J.; Kapsali, E.; Panayiotopoulou, S.; Bourantas, K. L. | 24-Nov-2015 | - |
Targeting Oncogenic Protein-Protein Interactions by Diversity Oriented Synthesis and Combinatorial Chemistry Approaches | Fokas, D.; Briasoulis, E.; Johannes, C.; Moussis, V.; Hatzimichael, E.; Tzakos, A. G. | 24-Nov-2015 | - |
Targeting Oncogenic Protein-Protein Interactions by Diversity Oriented Synthesis and Combinatorial Chemistry Approaches | Tzakos, A. G.; Fokas, D.; Johannes, C.; Moussis, V.; Hatzimichael, E.; Briasoulis, E. | 24-Nov-2015 | - |
Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules | Chaidos, A.; Makis, A.; Hatzimichael, E.; Tsiara, S.; Gouva, M.; Tzouvara, E.; Bourantas, K. L. | 24-Nov-2015 | - |
Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone | Christou, L.; Hatzimichael, E.; Chaidos, A.; Tsiara, S.; Bourantas, K. L. | 24-Nov-2015 | - |
Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone disease | Hatzimichael, E.; Dranitsaris, G.; Dasoula, A.; Benetatos, L.; Stebbing, J.; Crook, T.; Bourantas, K. L. | 24-Nov-2015 | - |